Skip to main content

Table 2 Comparison between the studied groups regarding computerized morphometric analysis

From: Efficacy of adipose—derived stromal vascular fraction in treatment of osteoarthritis: an experimental study

 

Group I

Group II

Group III

Test value•

P-value

Sig

  
 

a

b

a

b

     

Chondrocyte cell count

42.86 ± 6.28

20.75 ± 1.71

26.25 ± 3.30

42.10 ± 3.18

39.40 ± 2.88

71.262

0.000

HS

  

Articular cartilage thickness

99.00 ± 10.20

73.85 ± 12.52

56.05 ± 8.61

87.34 ± 9.99

76.36 ± 6.38

27.044

0.000

HS

  

OD Hx&E

87.16 ± 4.01

71.63 ± 3.58

71.10 ± 2.28

81.35 ± 3.18

80.48 ± 2.05

48.769

0.000

HS

  

OD Safranin

94.66 ± 4.68

67.32 ± 4.25

71.60 ± 3.49

81.77 ± 3.09

83.26 ± 5.47

62.713

0.000

HS

  

Post Hoc analysis by LSD

 

P1

P2

P3

P4

P5

P6

P7

P8

P9

P10

 Chondrocyte cell count cells/HPF

0.000

0.000

0.000

0.000

0.000

0.000

0.000

0.062

0.737

0.131

 Articular cartilage thickness

0.002

0.016

0.579

0.000

0.000

0.000

0.000

0.009

0.019

0.000

 OD Hx&E

0.678

0.000

0.000

0.000

0.000

0.000

0.000

0.477

0.002

0.000

 OD Safranin

0.024

0.000

0.000

0.000

0.000

0.000

0.000

0.463

0.000

0.000

  1. Group I: healthy control, Group II: untreated, Group III: SVF treated, a: at 1 month, b: at 2 months, P-value < 0.01: highly significant (HS), •: One Way ANOVA test, cells/HPF: number of cells/High Power Field, OD: optical density, Hx&E: hematoxylin and eosin, Fisher's Least Significant Difference test: LSD, Vs: versus, P1: Group IIa Vs Group IIb, P2: Group IIa Vs Group IIIa, P3: Group IIa Vs Group IIIb, P4: Group IIa Vs Group I, P5: Group IIb Vs Group IIIa, P6: Group IIb Vs Group IIIb, P7: Group IIb Vs Group I, P8: Group IIIa Vs Group IIIb, P9: Group IIIa Vs Group I, P10: Group IIIb Vs Group I